DRDO's antiviral drug 2-DG unlikely to get quick nod for Covid treatment

Experts said the 2-DG drug had earlier been considered for treatment of influenza, way back in 1959, and subsequently for other infectious diseases such as Herpes. However, most of these studies were conducted in laboratories and there isn ’t much real world evidence on the drug’s efficacy, infectious disease experts that ET spoke to said.
Source: The Economic Times - Category: Consumer Health News Source Type: news